Abonnement à la biblothèque: Guest
International Journal of Medicinal Mushrooms

Publication de 12  numéros par an

ISSN Imprimer: 1521-9437

ISSN En ligne: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Clinical Trials for Medicinal Mushrooms: Experience with Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Lingzhi Mushroom)

Volume 7, Numéro 1&2, 2005, pp. 111-118
DOI: 10.1615/IntJMedMushr.v7.i12.110
Get accessGet access

RÉSUMÉ

Despite the popularity of medicinal mushrooms, most are not well researched in terms of clinical efficacy and toxicity. We have completed seven clinical trials of Ganoderma lucidum in several diseases including cancer, Type II diabetes, coronary heart disease, chronic hepatitis B, and neurasthenia. Most of these studies were randomized, double-blind, multi-centered and placebo controlled. The results arising from these studies are promising. For example, treatment with Ganopoly for 12 weeks showed hypoglycemic activity in Type II diabetes, improved the symptoms/signs of patients with coronary heart disease or neurasthenia, and produced some antiviral and liver protective effects in patients with chronic hepatitis B infection. However, the same treatment regimen did not result in any objective response in late-stage cancer patients, although some stable disease status was observed. Ganopoly appeared to enhance immune functions in some cancer patients, but the results have yet to be confirmed. Ganopoly was generally well tolerated. Overall, the findings from all these clinical studies suggest that Ganopoly may have multiple pharmacological activities, although the activities are minor, moderate, or lacking as a result of many factors, such as inappropriate dosage regimen, difficulties in finding suitable biomarkers and end points, large interpatient variability in responses to the treatment, and unknown mode of action. Well designed clinical studies are needed to explore the mode of action, efficacy and safety of G. lucidum in patients.

CITÉ PAR
  1. Jin Xingzhong, Ruiz Beguerie Julieta, Sze Daniel Man-yeun, Chan Godfrey CF, Jin Xingzhong, Ganoderma lucidum(Reishi mushroom) for cancer treatment, in Cochrane Database of Systematic Reviews, 2012. Crossref

  2. Roupas Peter, Keogh Jennifer, Noakes Manny, Margetts Christine, Taylor Pennie, Mushrooms and agaritine: A mini-review, Journal of Functional Foods, 2, 2, 2010. Crossref

  3. Roupas Peter, Keogh Jennifer, Noakes Manny, Margetts Christine, Taylor Pennie, The role of edible mushrooms in health: Evaluation of the evidence, Journal of Functional Foods, 4, 4, 2012. Crossref

  4. Giavasis Ioannis, Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals, Current Opinion in Biotechnology, 26, 2014. Crossref

  5. Gill Balraj Singh, Sharma Prateek, Kumar Raj, Kumar Sanjeev, Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling, Tumor Biology, 37, 3, 2016. Crossref

  6. Zhang Jue, Chen Jun-ming, Wang Xiao-xia, Xia Yong-mei, Cui Steve W., Li Jian, Ding Zhong-yang, Inhibitor or promoter? The performance of polysaccharides from Ganoderma lucidum on human tumor cells with different p53 statuses, Food & Function, 7, 4, 2016. Crossref

  7. Queirós Bruno, Barreira João C.M., Sarmento Ana Cristina, Ferreira Isabel C.F.R., In search of synergistic effects in antioxidant capacity of combined edible mushrooms, International Journal of Food Sciences and Nutrition, 60, sup6, 2009. Crossref

  8. Wasser Solomon P., Medicinal Properties and Clinical Effects of Medicinal Mushrooms, in Edible and Medicinal Mushrooms, 2017. Crossref

  9. Hsu Kai-Di, Cheng Kuan-Chen, From nutraceutical to clinical trial: frontiers in Ganoderma development, Applied Microbiology and Biotechnology, 102, 21, 2018. Crossref

  10. Linnakoski Riikka, Reshamwala Dhanik, Veteli Pyry, Cortina-Escribano Marta, Vanhanen Henri, Marjomäki Varpu, Antiviral Agents From Fungi: Diversity, Mechanisms and Potential Applications, Frontiers in Microbiology, 9, 2018. Crossref

  11. Cheong Peter Chiew Hing, Tan Chon Seng, Fung Shin Yee, Application of Wild Macrofungi as Anticancer Therapeutics, in Biology of Macrofungi, 2018. Crossref

  12. Cheong Peter Chiew Hing, Tan Chon Seng, Fung Shin Yee, Medicinal Mushrooms: Cultivation and Pharmaceutical Impact, in Biology of Macrofungi, 2018. Crossref

  13. Santa Herta Stutz Dalla, Romão Pedro Roosevelt Torres, Sovrani Vanessa, Oliveira Fabio Rodrigues, Peres Alessandra, Monteiro Marta Chagas, Dietary Polysaccharides and Immune Modulation, in Polysaccharides, 2015. Crossref

  14. Jin Xingzhong, Ruiz Beguerie Julieta, Sze Daniel Man-yuen, Chan Godfrey CF, Ganoderma lucidum (Reishi mushroom) for cancer treatment, Cochrane Database of Systematic Reviews, 2019, 1, 2016. Crossref

  15. Reis Filipa S., Martins Anabela, Vasconcelos M. Helena, Morales Patricia, Ferreira Isabel C.F.R., Functional foods based on extracts or compounds derived from mushrooms, Trends in Food Science & Technology, 66, 2017. Crossref

  16. Santa Herta Stutz Dalla, Romão Pedro Roosevelt Torres, Sovrani Vanessa, Oliveira Fabio Rodrigues, Peres Alessandra, Monteiro Marta Chagas, Dietary Polysaccharides and Immune Modulation, in Polysaccharides, 2014. Crossref

3055 Vues d'articles 52 Téléchargements d'articles Métrique
3055 VUES 52 TÉLÉCHARGEMENTS 16 Crossref CITATIONS Google
Scholar
CITATIONS

Articles avec un contenu similaire:

Chemopreventive and Tumoricidal Properties of Ling Zhi Mushroom Ganoderma lucidum (W. Curt.:Fr.) Lloyd (Aphyllophoromycetideae). Part I. Preclinical and Clinical Studies (Review) International Journal of Medicinal Mushrooms, Vol.6, 2004, issue 2
He Gao, Jin Lan, Yihuai Gao, Wenbo Tank, Shufeng Zhou
Yellow Brain Culinary-Medicinal Mushroom, Tremella mesenterica Ritz.:Fr. (Higher Basidiomycetes), is Subjectively but not Objectively Effective for Eradication of Helicobacter pylori: A Prospective Controlled Trial International Journal of Medicinal Mushrooms, Vol.14, 2012, issue 1
Ronit Gafni-Schieber, Solomon P. Wasser, Jesse Lachter, Yevgeny Yampolsky
A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) Extract in Patients with Coronary Heart Disease International Journal of Medicinal Mushrooms, Vol.6, 2004, issue 4
Guoliang Chen, Jingxian Ye, Yihuai Gao, Shufeng Zhou, Xihu Dai
A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.)Lloyd (Aphyllophoromycetideae) Extract in Patients with Type II Diabetes Mellitus International Journal of Medicinal Mushrooms, Vol.6, 2004, issue 1
Jin Lan, Jingxian Ye, Yihuai Gao, Shufeng Zhou, Xihu Dai
Therapeutic Potentials of Medicinal Mushrooms for Nonalcoholic Fatty Liver Disease: A Review of Current Evidence International Journal of Medicinal Mushrooms, Vol.23, 2021, issue 1
Hui-Chen Lo
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain